This trial is evaluating whether Treatment will improve 1 primary outcome, 6 secondary outcomes, and 6 other outcomes in patients with Sarcopenia. Measurement will happen over the course of 12 months.
This trial requires 32 total participants across 2 different treatment groups
This trial involves 2 different treatments. Treatment is the primary treatment being studied. Participants will all receive the same treatment. Some patients will receive a placebo treatment. The treatments being tested are in Phase 1 and are in the first stage of evaluation with people.
Participation is compensated
You will be compensated for participating in this trial.
Patients from any state can participate in this trial, so long as they are able to attend all treatment sessions.
There is not cost involved in participating in this trial, so insurance won't be necessary.